Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesTributes & ObitsFarewell event for Henrik Thomsen goes ahead in DenmarkCopenhagen University’s Herlev and Gentofte Hospital has hosted a farewell symposium for the contrast agent pioneer Prof. Henrik S. Thomsen. It was attended by 150 invited guests.Womens ImagingSpanish group spells out pros and cons of CEMWomens ImagingDutch team reveals growing acceptance of DBTNuclear MedicinePET scans identify people at early risk for cognitive declineUltrasoundLung POCUS can boost dyspnea diagnosis in emergency setting